GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Inventage Lab Inc (XKRX:389470) » Definitions » Beneish M-Score

Inventage Lab (XKRX:389470) Beneish M-Score : -1.23 (As of May. 12, 2024)


View and export this data going back to 2022. Start your Free Trial

What is Inventage Lab Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Warning Sign:

Beneish M-Score -1.23 higher than -1.78, which implies that the company might have manipulated its financial results.

The historical rank and industry rank for Inventage Lab's Beneish M-Score or its related term are showing as below:

XKRX:389470' s Beneish M-Score Range Over the Past 10 Years
Min: -1.23   Med: -1.23   Max: -1.23
Current: -1.23

During the past 5 years, the highest Beneish M-Score of Inventage Lab was -1.23. The lowest was -1.23. And the median was -1.23.


Inventage Lab Beneish M-Score Historical Data

The historical data trend for Inventage Lab's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Inventage Lab Beneish M-Score Chart

Inventage Lab Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Beneish M-Score
- - - - -1.23

Inventage Lab Quarterly Data
Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Beneish M-Score Get a 7-Day Free Trial Premium Member Only - - - - -1.23

Competitive Comparison of Inventage Lab's Beneish M-Score

For the Drug Manufacturers - Specialty & Generic subindustry, Inventage Lab's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Inventage Lab's Beneish M-Score Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Inventage Lab's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Inventage Lab's Beneish M-Score falls into.



Inventage Lab Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Inventage Lab for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 7.461+0.528 * 1.0059+0.404 * 2.2807+0.892 * 0.1767+0.115 * 1.4499
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 8.2019+4.679 * -0.338248-0.327 * 6.2437
=-1.23

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec23) TTM:Last Year (Dec22) TTM:
Total Receivables was ₩722.7 Mil.
Revenue was 450.817 + 64.774 + 93.85 + 48.71 = ₩658.2 Mil.
Gross Profit was 378.124 + 64.579 + 93.85 + 47.217 = ₩583.8 Mil.
Total Current Assets was ₩26,214.4 Mil.
Total Assets was ₩45,182.3 Mil.
Property, Plant and Equipment(Net PPE) was ₩12,970.1 Mil.
Depreciation, Depletion and Amortization(DDA) was ₩2,610.7 Mil.
Selling, General, & Admin. Expense(SGA) was ₩10,785.3 Mil.
Total Current Liabilities was ₩28,876.2 Mil.
Long-Term Debt & Capital Lease Obligation was ₩6,236.2 Mil.
Net Income was 2388.549 + -20292.926 + -5642.749 + -3447.041 = ₩-26,994.2 Mil.
Non Operating Income was 0 + 0 + 0 + 0 = ₩0.0 Mil.
Cash Flow from Operations was -1062.983 + -4461.729 + -2611.691 + -3574.944 = ₩-11,711.3 Mil.
Total Receivables was ₩548.0 Mil.
Revenue was 1272.021 + 1353.544 + 27.086 + 1071.033 = ₩3,723.7 Mil.
Gross Profit was 1271.636 + 1353.544 + -253.192 + 950.474 = ₩3,322.5 Mil.
Total Current Assets was ₩25,277.9 Mil.
Total Assets was ₩34,861.9 Mil.
Property, Plant and Equipment(Net PPE) was ₩7,554.8 Mil.
Depreciation, Depletion and Amortization(DDA) was ₩2,424.3 Mil.
Selling, General, & Admin. Expense(SGA) was ₩7,439.9 Mil.
Total Current Liabilities was ₩2,609.1 Mil.
Long-Term Debt & Capital Lease Obligation was ₩1,730.0 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(722.659 / 658.151) / (548.003 / 3723.684)
=1.098014 / 0.147167
=7.461

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(3322.462 / 3723.684) / (583.77 / 658.151)
=0.892251 / 0.886985
=1.0059

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (26214.43 + 12970.09) / 45182.343) / (1 - (25277.936 + 7554.824) / 34861.903)
=0.132747 / 0.058205
=2.2807

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=658.151 / 3723.684
=0.1767

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(2424.342 / (2424.342 + 7554.824)) / (2610.722 / (2610.722 + 12970.09))
=0.24294 / 0.16756
=1.4499

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(10785.343 / 658.151) / (7439.917 / 3723.684)
=16.387338 / 1.997999
=8.2019

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((6236.167 + 28876.177) / 45182.343) / ((1730.027 + 2609.08) / 34861.903)
=0.777125 / 0.124466
=6.2437

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(-26994.167 - 0 - -11711.347) / 45182.343
=-0.338248

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Inventage Lab has a M-score of -1.23 signals that the company is likely to be a manipulator.


Inventage Lab Beneish M-Score Related Terms

Thank you for viewing the detailed overview of Inventage Lab's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Inventage Lab (XKRX:389470) Business Description

Traded in Other Exchanges
N/A
Address
24, Dunchon-daero 388 beon-gil, 612, Woolim Lions Valley 3, Jungwon-gu, Gyeonggi-do, Seongnam-si, KOR, 13403
Inventage Lab Inc operates medical technology development businesses. It engages in the development of an innovative Drug Delivery System (DDS). It has developed Laminar FluiDigm, a microfluidics-based novel platform technology that builds the foundation for IVL- DrugFluidic and IVL-GeneFluidic, which are specific platform technologies used for developing and manufacturing long-acting injectables and gene-delivery therapeutics.

Inventage Lab (XKRX:389470) Headlines

No Headlines